Winslow Capital Management, LLC Abb Vie Inc. Transaction History

Winslow Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $253 Million - $287 Million	-2,375,770 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $250 Million - $278 Million	2,375,770 New	2,375,770 $268 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $385 - $453	-5 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $92 - $123	-1 Reduced 16.67%	5 $0
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $419 - $535	6	6 $1,000

3,694

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Winslow Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Winslow Capital Management, LLC with notifications on news.